PROPANTHELINE BROMIDE Drug Patent Profile
Which patents cover Propantheline Bromide, and what generic alternatives are available?
Propantheline Bromide is a drug marketed by Ascot, Heather, Hikma, Impax Labs, Mylan, Par Pharm, Pvt Form, Sandoz, Tablicaps, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in PROPANTHELINE BROMIDE is propantheline bromide. There is one drug master file entry for this compound. Additional details are available on the propantheline bromide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROPANTHELINE BROMIDE?
- What are the global sales for PROPANTHELINE BROMIDE?
- What is Average Wholesale Price for PROPANTHELINE BROMIDE?
Summary for PROPANTHELINE BROMIDE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,747 |
| DailyMed Link: | PROPANTHELINE BROMIDE at DailyMed |
Recent Clinical Trials for PROPANTHELINE BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital Universitário Professor Edgard Santos | Phase 1 |
| Chongqing Medical University | Phase 4 |

